FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / Press Releases / Read Press Release

Print

Capitala Group Leads $27.3MM Investment in Optio RX

July 24, 2018, 07:00 AM
Filed Under: Pharmaceuticals


Capitala Group, a provider of capital to lower and traditional middle market companies, announced that it recently originated a combination of a senior secured debt facility and minority equity totaling $27.3 million to support Cold Bore Capital in the formation of Optio RX, LLC (Optio).

Based out of Nashville, TN, Optio is an owner and operator of specialty compounding pharmacies and home infusion providers licensed across the United States. Optio currently specializes in providing medication and care in the fertility, veterinary and hemophilia segments. Capitala’s investment will help fund the company’s next phase of growth as it looks to acquire additional specialty pharmacies across the country.







Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.